Back to Results
First PageMeta Content
Pediatrics / Medicine / Health / Channelopathy / Cystic fibrosis


IPO for Maine Angel PHARMACEUTICAL Portfolio Company
Add to Reading List

Document Date: 2014-12-19 10:19:12

Open Document

File Size: 24,91 KB

Share Result on Facebook

City

CRBP NORWOOD / /

Company

Corbus Pharmaceuticals Holdings Inc. / Corbus Pharmaceuticals Corbus Pharmaceuticals / Corbus Pharmaceuticals Commences Trading / /

Currency

USD / /

Event

FDA Phase / Funding / /

IndustryTerm

stage biopharmaceutical / treatment of cystic fibrosis / pharmaceutical / /

MedicalCondition

serious diseases / diffuse scleroderma / scleroderma / inflammatory resolution / cystic fibrosis / inflammation / effect turning chronic inflammation / inflammatory diseases / fibrosis / rare life-threatening inflammatory-fibrotic diseases / systemic sclerosis / /

Organization

Securities and Exchange Commission / /

Person

Yuval Cohen / Resunab / /

Position

Chief Executive Officer / candidate / /

Product

Resunab™ / /

Technology

drug development / /

URL

www.CorbusPharma.com / /

SocialTag